Evidence map›Paper›PMID 31101754›Full record

ArticleHaematologica2020

Sialyltransferase inhibition leads to inhibition of tumor cell interactions with E-selectin, VCAM1, and MADCAM1, and improves survival in a human multiple myeloma mouse model.

Alessandro Natoni, Mariah L Farrell, Sophie Harris, Carolyne Falank, Lucy Kirkham-McCarthy, Matthew S Macauley, Michaela R Reagan, Michael O'Dwyer

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Sialylation Inhibition Impairs Migration and Promotes Adhesion of GBM Cells.International journal of molecular sciences · 2025
    Article
  7. Adhesion to aggression: unravelling sLeClinical & experimental metastasis · 2025
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. PSGL-1 decorated with sialyl LewisScientific reports · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. [Latest Findings on the Mechanism of the Interaction Between Multiple Myeloma Cells and Bone Marrow Microenvironment].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Alessandro NatoniApoptosis Research Center, National University of Ireland, Galway, Ireland.
Mariah L FarrellMaine Medical Center Research Institute, Scarborough, ME, USA.
Sophie HarrisMaine Medical Center Research Institute, Scarborough, ME, USA.
Carolyne FalankMaine Medical Center Research Institute, Scarborough, ME, USA.
Lucy Kirkham-McCarthyApoptosis Research Center, National University of Ireland, Galway, Ireland.
Matthew S MacauleyDepartment of Chemistry and Department of Medical Microbiology and Immunology, University of Alberta, Alberta, Canada.
Michaela R ReaganMaine Medical Center Research Institute, Scarborough, ME, USA.
Michael O'DwyerApoptosis Research Center, National University of Ireland, Galway, Ireland michael.odwyer@nuigalway.ie.
Ollscoil na Gaillimhe – University of Galway · IEMaine Medical Center · USMaine Medical Center Research Institute · USUniversity of Alberta · CAUniversity of Maine · US

Funding

Understanding Factors Influencing COVID-19 Testing and Vaccination in Immigrant Low-income and Homeless Populations and Testing Targeted InterventionsU54GM115516 · NIGMS · MAINEHEALTH · PI CLIFFORD JAMES ROSEN · 2017 to 2026
$51.6M
The role of night shift work in metabolic disorders during and after pregnancyP20GM121301 · NIGMS · MAINEHEALTH · PI CLIFFORD JAMES ROSEN · 2017 to 2026
$25.1M
Progenitor Cell Analysis CoreP30GM106391 · NIGMS · MAINEHEALTH · PI WOJCHOWSKI, DON MICHAEL · 2013 to 2017
$5.7M
Phase III COBRE in Vascular BiologyP30GM103392 · NIGMS · MAINEHEALTH · PI ST. GERMAIN, DONALD L. · 2012 to 2016
$4.7M
Skeletal Phenotyping CoreP30AR066261 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI KRONENBERG, HENRY M. · 2014 to 2018
$3.5M
NIAMS NIH HHS P30 AR066261NIGMS NIH HHS P20 GM121301NIGMS NIH HHS P30 GM103392NIGMS NIH HHS P30 GM106391NIGMS NIH HHS U54 GM115516
6 · The paper itself

Abstract

Aberrant glycosylation resulting from altered expression of sialyltransferases, such as ST3 β-galactoside α2-3-sialyltransferase 6, plays an important role in disease progression in multiple myeloma (MM). Hypersialylation can lead to increased immune evasion, drug resistance, tumor invasiveness, and disseminated disease. In this study, we explore the

Indexed as

Multiple MyelomaAnimalsBortezomibCell Adhesion MoleculesCell CommunicationE-SelectinHumansMiceMucoproteinsSialyltransferasesTumor MicroenvironmentBortezomibCell Adhesion MoleculesE-SelectinMADCAM1 protein, humanMucoproteinsSialyltransferases

Identifiers

PMID31101754
PMCPMC7012485
OpenAlexW2946604950

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.